(Q38622097)

4 September 2017

1 reference

title

An evaluation of the contribution of bone mass measurements to clinical practice (English)

1 reference

4 September 2017

Fogelman I

1

1 reference

4 September 2017

1 January 1989

1 reference

Seminars in Nuclear Medicine

4 September 2017

1 reference

4 September 2017

19

1 reference

4 September 2017

1

1 reference

4 September 2017

62-68

1 reference

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

4 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Prospective trial of oestrogen and calcium in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

MEASUREMENT OF BONE MINERAL IN VIVO: AN IMPROVED METHOD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Measurement of bone mineral content in human vertebrae and hip by dual photon absorptiometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Should women get screening bone mass measurements?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Should perimenopausal women be screened for osteoporosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

More on bone mineral screening for osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

The relationship of bone strength and bone quantity in health, disease, and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Effects of fluoride on calcium metabolism in osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Changes in metacarpal mineral content and density in normal male and female subjects with age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Rise in plasma alkaline phosphatase at the menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Early menopausal changes in bone mass and sex steroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Relative contributions of aging and estrogen deficiency to postmenopausal bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Prediction of rapid bone loss in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Consensus on preventing osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Recovery from steroid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Reversible bone loss in anorexia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Risk factors for hip fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Tamoxifen and benign breast problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2889%2980036-4

10.1016/S0001-2998(89)80036-4

7 January 2021

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

2652308